查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423921

肿瘤学人工智慧市场、份额、规模、趋势、产业分析报告：按癌症类型、成分、治疗类型、地区和细分市场预测，2024-2032年

AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球肿瘤人工智慧市场预计将达到 167.2 亿美元。 该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于癌症发生率上升，预计市场将大幅增长，从而推动对用于癌症诊断、治疗和分析的技术先进产品的需求。 例如，国际癌症研究机构（IARC）预测，2023年新增病例将超过2,070万例。 此外，人工智慧在早期检测和降低死亡率方面发挥着重要作用，特别是透过有效的筛检计画。

人工智慧与深度学习和高效能运算的进步相结合，利用多组学分析产生的大量数据集正在彻底改变肿瘤学领域。 人工智慧与肿瘤学的整合涵盖了癌症管理各个阶段的新方法，包括癌症检测、筛检、诊断和分类。 人工智慧正在帮助表征癌症基因组学、分析肿瘤微环境、评估预后和预测生物标誌物，并制定后续护理和药物发现策略。 人工智慧的综合应用正在提高癌症研究和治疗的精度和效率。

技术的快速进步，特别是在准确性、安全性和自动化方面，预计将在可预见的未来推动市场成长。 作为一种新的变革性技术，人工智慧在显着提高肿瘤筛检率方面发挥关键作用。 因此，公共和私营部门都将重点放在资助和大力投资研发（R＆D）计划上，以推动基于人工智慧的肿瘤筛检产品。

例如，2023年3月，Altera获得9,000万美元融资。 这笔资金将支持 ArteraAI 前列腺测试的启动和商业化，这是第一个用于预测局部前列腺癌治疗结果的测试，这是一个重要的里程碑。 这表明人们对肿瘤学领域创新的人工智慧驱动解决方案的认识和支持不断增强，这些解决方案有可能提高筛检效率和治疗决策。

该行业的主要参与者策略性地专注于开发创新产品，以促进癌症的早期诊断、满足不断增长的需求并推进其研发管线。我们正在致力于建立合作伙伴关係和联合研究。 例如，2022年12月，阿斯特捷利康开始与Clinicalink合作推出专注于肺癌的AI计画。 该计画的主要目标是早期发现肺癌，有助于制定更有效的治疗策略。

肿瘤学人工智慧市场报告亮点

软体解决方案产业占据最大份额，主要是由于采用基于人工智慧的服务来改善临床结果。

由于脑肿瘤病例数量不断增加和巨大的未满足的医疗需求，脑肿瘤领域预计将增长最快

该市场以北美为主，因为它拥有丰富的医疗基础设施，并且有提供医疗解决方案的人工智慧玩家。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章肿瘤学领域的全球人工智慧市场洞察

  • 肿瘤学人工智慧市场 - 治疗类型概览
  • 肿瘤学人工智慧市场动态
    • 促进因素和机会
      • 癌症发生率上升
      • 治疗优化
    • 抑制因素和挑战
      • 资料隐私与安全问题
  • PESTEL 分析
  • 肿瘤人工智慧市场、治疗类型趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章全球肿瘤 AI 市场（以癌症类型）

  • 主要发现
  • 简介
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 大肠癌
  • 脑肿瘤
  • 其他

第 6 章按组成部分划分的全球肿瘤人工智慧市场

  • 主要发现
  • 简介
  • 软体解决方案
  • 硬体
  • 服务

第 7 章按治疗类型划分的全球肿瘤人工智慧市场

  • 主要发现
  • 简介
  • 化疗
  • 放射治疗
  • 免疫治疗
  • 其他

第 8 章全球肿瘤学人工智慧市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年肿瘤学人工智慧市场评估（按地区）
  • 肿瘤学人工智慧市场 - 北美
    • 北美：肿瘤人工智慧市场，按癌症类型，2019-2032 年
    • 北美：肿瘤人工智慧市场，依治疗类型，2019-2032 年
    • 北美：肿瘤人工智慧市场，按组成部分，2019-2032 年
    • 肿瘤学人工智慧市场 - 美国
    • 肿瘤学人工智慧市场 - 加拿大
  • 肿瘤学人工智慧市场 - 欧洲
    • 欧洲：肿瘤人工智慧市场，按癌症类型，2019-2032 年
    • 欧洲：肿瘤学人工智慧市场，按治疗类型，2019-2032 年
    • 欧洲：肿瘤学人工智慧市场，按组成部分，2019-2032 年
    • 肿瘤学人工智慧市场 - 英国
    • 肿瘤学人工智慧市场 - 法国
    • 肿瘤学人工智慧市场 - 德国
    • 肿瘤学人工智慧市场 - 义大利
    • 肿瘤学人工智慧市场 - 西班牙
    • 肿瘤学人工智慧市场 - 荷兰
    • 肿瘤学人工智慧市场 - 俄罗斯
  • 肿瘤学人工智慧市场 - 亚太地区
      亚太地区：肿瘤学人工智慧市场，按癌症类型，2019-2032 年
    • 亚太地区：肿瘤学人工智慧市场，按治疗类型，2019-2032 年
    • 亚太地区：肿瘤学人工智慧市场，按组成部分，2019-2032 年
    • 肿瘤学人工智慧市场 - 中国
    • 肿瘤学人工智慧市场 - 印度
    • 肿瘤学人工智慧市场 - 马来西亚
    • 肿瘤学人工智慧市场 - 日本
    • 肿瘤学人工智慧市场 - 印尼
    • 韩国肿瘤学人工智慧市场
  • 肿瘤学人工智慧市场 - 中东和非洲
    • 中东和非洲：肿瘤学人工智慧市场，按癌症类型，2019-2032 年
    • 中东和非洲：肿瘤学人工智慧市场，按治疗类型，2019-2032 年
    • 中东和非洲：肿瘤学人工智慧市场，按组成部分，2019-2032 年
    • 肿瘤学人工智慧市场 - 沙乌地阿拉伯
    • 肿瘤学人工智慧市场 - 阿联酋
    • 肿瘤学人工智慧市场 - 以色列
    • 肿瘤学人工智慧市场 - 南非
  • 肿瘤学人工智慧市场 - 拉丁美洲
    • 拉丁美洲：肿瘤人工智慧市场，按癌症类型，2019-2032 年
    • 拉丁美洲：肿瘤人工智慧市场，依治疗类型，2019-2032 年
    • 拉丁美洲：肿瘤人工智慧市场，按组成部分，2019-2032 年
    • 肿瘤学人工智慧市场 - 墨西哥
    • 肿瘤学人工智慧市场 - 巴西
    • 肿瘤学人工智慧市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
Product Code: PM4153

The global AI in oncology market size is expected to reach USD 16.72 billion by 2032, according to a new study by Polaris Market Research. The report "AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is poised for substantial growth due to the rising incidence of cancer, driving the demand for technologically advanced products for cancer diagnosis, treatment, and analysis. For instance, the International Agency for Research on Cancer (IARC) estimates over 20.7 million new cases, in 2023. Furthermore, AI plays a crucial role in early detection, contributing to mortality reduction, particularly through effective screening programs.

AI is revolutionizing the field of oncology by leveraging vast datasets generated through multi-omics analyses, coupled with advancements in deep learning and high-performance computing. This integration of AI into oncology encompasses novel approaches for various stages of cancer management, including detection, screening, diagnosis, and classification. AI is instrumental in characterizing cancer genomics, analyzing the tumor microenvironment, assessing prognostic and predictive biomarkers, and formulating strategies for follow-up care and drug discovery. This comprehensive application of AI is enhancing the precision and efficiency of cancer research and treatment.

The rapid progression of technology, particularly in terms of accuracy, safety, and automation, is poised to drive market growth in the foreseeable future. AI, as an emerging and transformative technology, plays a crucial role in significantly increasing screening rates in the field of oncology. Consequently, both public and private organizations are directing their focus towards substantial funding and investment in research and development (R&D) initiatives aimed at advancing AI-based oncology screening products.

For instance, in March 2023, Artera secured funding of nearly, USD 90 million. This funding is earmarked for the launch and distribution of the ArteraAI Prostate Test, marking a significant milestone as the first developed test designed to predict therapy outcomes in localized prostate cancer. This illustrates the growing recognition and support for innovative AI-driven solutions in oncology, with the potential to enhance screening efficiency and therapeutic decision-making.

Key industry players are strategically engaging in collaborations and partnerships, with a primary emphasis on the development of innovative products aimed at facilitating early cancer diagnosis, addressing increasing demand, and advancing research and development pipelines. For instance, in December 2022, AstraZeneca initiated a collaboration with Clinithink to embark on an AI project focused on lung cancer. The primary objective of this project is the early detection of lung cancer, thereby contributing to the formulation of more effective treatment strategies.

AI in Oncology Market Report Highlights

Software solutions segment held the largest share, primarily due to adoption of AI based services for better clinical outcomes

Brain tumor segment expected to grow at the fastest rate, owing to rising cases of brain tumors and huge unmet medical needs

North America dominated the market, as the region has better healthcare infrastructure, coupled with AI players offering healthcare solutions

The global players include Azra AI, IBM, Siemens Healthcare, Intel, GE HealthCare, NVIDIA, Digital Diagnostics, ConcertAI, Median Technologies, and PathAI

Polaris Market Research has segmented the AI in oncology market report based on component, cancer type, treatment type, and region:

AI in Oncology, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Software Solutions
  • Hardware
  • Services

AI in Oncology, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

AI in Oncology, Treatment Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Others

AI in Oncology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Oncology Market Insights

  • 4.1. AI in Oncology Market - Treatment Type Snapshot
  • 4.2. AI in Oncology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cancer
      • 4.2.1.2. Treatment Optimization
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Oncology Market Treatment Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Oncology Market, by Cancer Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global AI in Oncology Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global AI in Oncology Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 5.5. Prostate Cancer
    • 5.5.1. Global AI in Oncology Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 5.6. Colorectal Cancer
    • 5.6.1. Global AI in Oncology Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
  • 5.7. Brain Tumor
    • 5.7.1. Global AI in Oncology Market, by Brain Tumor, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global AI in Oncology Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global AI in Oncology Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 6.3. Software Solutions
    • 6.3.1. Global AI in Oncology Market, by Software Solutions, by Region, 2019-2032 (USD Billion)
  • 6.4. Hardware
    • 6.4.1. Global AI in Oncology Market, by Hardware, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global AI in Oncology Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global AI in Oncology Market, by Treatment Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.3. Chemotherapy
    • 7.3.1. Global AI in Oncology Market, by Chemotherapy, By Region, 2019-2032 (USD Billion)
  • 7.4. Radiotherapy
    • 7.4.1. Global AI in Oncology Market, by Radiotherapy, By Region, 2019-2032 (USD Billion)
  • 7.5. Immunotherapy
    • 7.5.1. Global AI in Oncology Market, by Immunotherapy, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global AI in Oncology Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global AI in Oncology Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. AI in Oncology Market - North America
    • 8.3.1. North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.4. AI in Oncology Market - U.S.
      • 8.3.4.1. U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.5. AI in Oncology Market - Canada
      • 8.3.5.1. Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.4. AI in Oncology Market - Europe
    • 8.4.1. Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.4. AI in Oncology Market - UK
      • 8.4.4.1. UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.5. AI in Oncology Market - France
      • 8.4.5.1. France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.6. AI in Oncology Market - Germany
      • 8.4.6.1. Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.7. AI in Oncology Market - Italy
      • 8.4.7.1. Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.8. AI in Oncology Market - Spain
      • 8.4.8.1. Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.9. AI in Oncology Market - Netherlands
      • 8.4.9.1. Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.10. AI in Oncology Market - Russia
      • 8.4.10.1. Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.5. AI in Oncology Market - Asia Pacific
    • 8.5.1. Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.4. AI in Oncology Market - China
      • 8.5.4.1. China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.5. AI in Oncology Market - India
      • 8.5.5.1. India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.6. AI in Oncology Market - Malaysia
      • 8.5.6.1. Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.7. AI in Oncology Market - Japan
      • 8.5.7.1. Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.8. AI in Oncology Market - Indonesia
      • 8.5.8.1. Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.9. AI in Oncology Market - South Korea
      • 8.5.9.1. South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.6. AI in Oncology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.4. AI in Oncology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.5. AI in Oncology Market - UAE
      • 8.6.5.1. UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.6. AI in Oncology Market - Israel
      • 8.6.6.1. Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.7. AI in Oncology Market - South Africa
      • 8.6.7.1. South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.7. AI in Oncology Market - Latin America
    • 8.7.1. Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.4. AI in Oncology Market - Mexico
      • 8.7.4.1. Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.5. AI in Oncology Market - Brazil
      • 8.7.5.1. Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.6. AI in Oncology Market - Argentina
      • 8.7.6.1. Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Azra AI
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. IBM
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Siemens Healthcare GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Intel Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GE HealthCare
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. NVIDIA Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Digital Diagnostics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. ConcertAI
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Median Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. PathAI
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 2 Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 3 Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 4 AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 6 North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 7 North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 10 U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 11 Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 12 Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 13 Canada: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 15 Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 16 Europe: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 17 UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 18 UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 19 UK: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 21 France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 22 France: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 23 Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 25 Germany: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 27 Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 28 Italy: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 29 Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 30 Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 31 Spain: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 34 Netherlands: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 35 Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 36 Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 37 Russia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 41 China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 42 China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 43 China: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 45 India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 46 India: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 49 Malaysia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 51 Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 52 Japan: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 55 Indonesia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 58 South Korea: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 65 UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 66 UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 67 UAE: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 68 Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 70 Israel: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 73 South Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 76 Latin America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 79 Mexico: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 82 Brazil: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 85 Argentina: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global AI in Oncology Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Component
  • Figure 7. Global AI in Oncology Market, by Component, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Cancer Type
  • Figure 9. Global AI in Oncology Market, by Cancer Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Treatment Type
  • Figure 11. Global AI in Oncology Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 12. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - AI in Oncology Market